Maison de Santé Triangle: what changed
What changed
Maison de Santé Triangle
NACE 86.210, General medical practice
filed annual accounts (NBB)
Net result for the year
€63,408
2024 · €120,832-€57,423
Equity
€334,277
2024 · €270,869+€63,408
Cash
€338,677
2024 · €331,185+€7,492
Balance sheet total
€467,759
2024 · €403,961+€63,799
Largest movements
Assets
- Receivables within one year +€46,570
up €46,570 (+69.8%), from €66,674 to €113,244
of which Other amounts receivable: +€48,630
- Deferred charges and accrued income +€8,637
up €8,637 (+196%), from €4,399 to €13,035
- Cash +€7,492
up €7,492 (+2.3%), from €331,185 to €338,677
mainly Net result for the year (+€63,408) and Depreciation (+€1,967)
Equity and liabilities
- Reserves +€63,000
up €63,000 (+84.0%), from €75,000 to €138,000
Income statement
- Staff costs +€128,247
up €128,247 (+27.9%), from €459,661 to €587,907
- Gross operating margin +€70,648
up €70,648 (+12.1%), from €583,101 to €653,749
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€120,832
Gross operating margin
+€70,648
Staff costs
-€128,247
Depreciation
+€601
Financial income
-€88
Financial charges
-€339
Result 2025
€63,408
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€10,560
Investment
-€3,068
Financing
€0
Cash 2024
€331,185
From operations (derived)
+€10,560
Net result for the year
+€63,408
Depreciation
+€1,967
Receivables within one year
-€46,570
Deferred charges and accrued income
-€8,637
Debts within one year
+€391
Investment (derived)
-€3,068
Investment in fixed assets (net)
-€3,068
Cash 2025
€338,677
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €403,961 | €467,759 | +€63,799 | +15.8% |
| Fixed assets | 21/28 | €1,702 | €2,803 | +€1,101 | +64.7% |
| Tangible fixed assets | 22/27 | €1,702 | €2,703 | +€1,001 | +58.8% |
| Plant, machinery and equipment | 23 | €1,702 | - | -€1,702 | |
| Furniture and vehicles | 24 | - | €2,703 | +€2,703 | |
| Financial fixed assets | 28 | - | €100 | +€100 | |
| Current assets | 29/58 | €402,259 | €464,957 | +€62,698 | +15.6% |
| Amounts receivable within one year | 40/41 | €66,674 | €113,244 | +€46,570 | +69.8% |
| Trade receivables | 40 | €36,498 | €34,438 | -€2,060 | -5.6% |
| Other amounts receivable | 41 | €30,176 | €78,806 | +€48,630 | +161% |
| Cash at bank and in hand | 54/58 | €331,185 | €338,677 | +€7,492 | +2.3% |
| Deferred charges and accrued income | 490/1 | €4,399 | €13,035 | +€8,637 | +196% |
| Total equity and liabilities | 10/49 | €403,961 | €467,759 | +€63,799 | +15.8% |
| Equity | 10/15 | €270,869 | €334,277 | +€63,408 | +23.4% |
| Reserves | 13 | €75,000 | €138,000 | +€63,000 | +84.0% |
| Profit (loss) carried forward | 14 | €195,869 | €196,277 | +€408 | +0.2% |
| Amounts payable | 17/49 | €133,092 | €133,483 | +€391 | +0.3% |
| Amounts payable within one year | 42/48 | €133,092 | €133,483 | +€391 | +0.3% |
| Financial debts | 43 | €31,328 | €19,500 | -€11,828 | -37.8% |
| Credit institutions | 430/8 | €31,328 | €19,500 | -€11,828 | -37.8% |
| Trade debts | 44 | €6,663 | €19,434 | +€12,771 | +192% |
| Suppliers | 440/4 | €6,663 | €19,434 | +€12,771 | +192% |
| Taxes, remuneration and social security | 45 | €94,468 | €94,548 | +€80 | +0.1% |
| Taxes | 450/3 | €9,380 | €11,480 | +€2,100 | +22.4% |
| Remuneration and social security | 454/9 | €85,088 | €83,069 | -€2,020 | -2.4% |
| Remuneration, social security and pensions | 62 | €459,661 | €587,907 | +€128,247 | +27.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,569 | €1,967 | -€601 | -23.4% |
| Gross operating margin | 9900 | €583,101 | €653,749 | +€70,648 | +12.1% |
| Operating profit (loss) | 9901 | €120,871 | €63,874 | -€56,997 | -47.2% |
| Financial income | 75/76B | €88 | - | -€88 | |
| Recurring financial income | 75 | €88 | - | -€88 | |
| Financial charges | 65/66B | €127 | €466 | +€339 | +266% |
| Recurring financial charges | 65 | €127 | €466 | +€339 | +266% |
| Profit (loss) for the period before taxes | 9903 | €120,832 | €63,408 | -€57,423 | -47.5% |
| Profit (loss) for the period | 9904 | €120,832 | €63,408 | -€57,423 | -47.5% |
| Profit (loss) for the period to be appropriated | 9905 | €120,832 | €63,408 | -€57,423 | -47.5% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 2 November 2026 via checked.be.